166 related articles for article (PubMed ID: 36056891)
1. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
Cortés-Penfield N; Ryder JH
Clin Infect Dis; 2023 Jan; 76(2):346-350. PubMed ID: 36056891
[TBL] [Abstract][Full Text] [Related]
2. Rare presentation of necrotising fasciitis and streptococcal toxic shock syndrome by group A streptococcus.
Saeed S; Alothman S; Ahmed L; Donaldson B
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28954758
[No Abstract] [Full Text] [Related]
3. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.
Babiker A; Li X; Lai YL; Strich JR; Warner S; Sarzynski S; Dekker JP; Danner RL; Kadri SS
Lancet Infect Dis; 2021 May; 21(5):697-710. PubMed ID: 33333013
[TBL] [Abstract][Full Text] [Related]
4. Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study.
Hamada S; Nakajima M; Kaszynski RH; Otaka S; Goto H; Matsui H; Fushimi K; Yamaguchi Y; Yasunaga H
Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):263-270. PubMed ID: 34755257
[TBL] [Abstract][Full Text] [Related]
5. [Toxic shock-like syndrome caused by streptococci].
van Dissel JT; Kullberg BJ; van der Meer JW
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1452-5. PubMed ID: 10443259
[TBL] [Abstract][Full Text] [Related]
6. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.
Carapetis JR; Jacoby P; Carville K; Ang SJ; Curtis N; Andrews R
Clin Infect Dis; 2014 Aug; 59(3):358-65. PubMed ID: 24785239
[TBL] [Abstract][Full Text] [Related]
8. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
Stevens DL
Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report.
Yokota K; Kawakami K
J Infect Chemother; 2024 Aug; 30(8):785-788. PubMed ID: 38185364
[TBL] [Abstract][Full Text] [Related]
10. Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome.
Andreoni F; Zürcher C; Tarnutzer A; Schilcher K; Neff A; Keller N; Marques Maggio E; Poyart C; Schuepbach RA; Zinkernagel AS
J Infect Dis; 2017 Jan; 215(2):269-277. PubMed ID: 27247345
[TBL] [Abstract][Full Text] [Related]
11. Infections due to group A streptococcus: new concepts and potential treatment strategies.
Norrby SR; Norrby-Teglund A
Ann Acad Med Singap; 1997 Sep; 26(5):691-3. PubMed ID: 9494680
[TBL] [Abstract][Full Text] [Related]
12. Invasive group A streptococcal disease.
Stevens DL
Infect Agents Dis; 1996 Jun; 5(3):157-66. PubMed ID: 8805078
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive antibiotic therapy with clindamycin or linezolid in patients with group A streptococcus (GAS) meningitis.
Rezahosseini O; Roed C; Gitz Holler J; Frimodt-Møller N; Harboe ZB
Infect Dis (Lond); 2023 Oct; 55(10):751-753. PubMed ID: 37415443
[No Abstract] [Full Text] [Related]
14. Non-Necrotizing Soft Tissue Infection and Streptococcal Toxic Shock Syndrome Caused by a Novel Streptococcus pyogenes Subtype (emm76.10).
Hashiyama T; Mori N; Fukushima Y; Takahashi T
Jpn J Infect Dis; 2020 Sep; 73(5):373-376. PubMed ID: 32350222
[TBL] [Abstract][Full Text] [Related]
15. Retiform Purpura as a Sign of Necrotizing Cellulitis in an Immunocompetent Boy.
Aboul-Fettouh N; Nguyen KD; Dominguez AR
Pediatr Emerg Care; 2020 Nov; 36(11):e646-e648. PubMed ID: 32970024
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
17. Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes.
Russell NE; Pachorek RE
Ann Pharmacother; 2000; 34(7-8):936-9. PubMed ID: 10928407
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.
Horn DL; Roberts EA; Shen J; Chan JD; Bulger EM; Weiss NS; Lynch JB; Bryson-Cahn C; Robinson BRH
Clin Infect Dis; 2021 Dec; 73(11):e4592-e4598. PubMed ID: 33151283
[TBL] [Abstract][Full Text] [Related]
19. [Toxic shock-like syndrome caused by streptococci--treated with clindamycin].
Nørgaard M
Ugeskr Laeger; 1997 Apr; 159(16):2396-7. PubMed ID: 9163118
[TBL] [Abstract][Full Text] [Related]
20. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
